Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

ELMORE PATENT LAW GROUP, PC

WESTFORD, MA US

1. 20090286729 Epidermal Growth Factor Receptor Antagonists and Methods of Use 11-19-2009
2. 20090281324 PROCESSES FOR THE PREPARATION OF O-[5-(4-AMINO-THIAZOL-2-YL)-PYRIDIN-2-YLMETHYL]-HYDROXYLAMINE 11-12-2009
3. 20090281293 PROCESSES FOR THE PREPARATION OF 2 FLUORO 6-11 BICYCLIC ERYTHROMYCIN DERIVATIVES 11-12-2009
4. 20090281050 ANTI-BACTERIAL ACTIVITY OF 9-HYDROXY DERIVATIVES OF 6,11-BICYCLOLIDES 11-12-2009
5. 20090275548 COMPOUNDS AND METHODS FOR ACTIVATED THERAPY 11-05-2009
6. 20090274686 NUCLEOSIDE PHOSPHONATE DERIVATIVES - The present invention discloses compounds of formula or or pharmaceutically acceptable salts esters 11-05-2009
7. 20090274657 DIFLUOROMETHYL-CONTAINING MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS 11-05-2009
8. 20090270457 6,11-BICYCLOLIDES: BRIDGED BIARYL MACROLIDE DERIVATIVES 10-29-2009
9. 20090264380 6,11-BRIDGED BIARYL MACROLIDES - The present invention discloses compounds of formula I II or X or pharmaceutically acceptable salts 10-22-2009
10. 20090252814 USE OF XENON FOR ORGAN PROTECTION - Use of xenon is described 10-08-2009
11. 20090238794 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS 09-24-2009
12. 20090221702 COMPOUNDS - the use of a compound of the Formula: wherein R 09-03-2009
13. 20090221441 THREE-DIMENSIONAL CELLULAR ARRAY CHIP AND PLATFORM FOR TOXICOLOGY ASSAYS 09-03-2009
14. 20090214650 Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers 08-27-2009
15. 20090209758 QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY 08-20-2009
16. 20090209569 SELECTIVE OPIOID COMPOUNDS - compounds of Formula I or II or pharmaceutically acceptable salts 08-20-2009
17. 20090209547 C-8 HALOGENATED MACROLIDES - The present invention discloses compounds of formula or pharmaceutically acceptable salts esters or prodrugs thereof: 08-20-2009
18. 20090206040 SYSTEMS AND METHODS FOR REMOVING FINELY DISPERSED PARTICULATE MATTER FROM A FLUID STREAM 08-20-2009
19. 20090202486 DIFLUORINATED TRIPEPTIDES AS HCV SERINE PROTEASE INHIBITORS 08-13-2009
20. 20090202485 HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS 08-13-2009
21. 20090197888 FLUORINATED TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS 08-06-2009
22. 20090191153 OXIMYL MACROCYCLIC DERIVATIVES - compounds of Formula I or pharmaceutically acceptable salts esters 07-30-2009
23. 20090191151 TRIAZOLE-CONTAINING MACROCYCLIC HCV SERINE PROTEASE INHIBITORS 07-30-2009
24. 20090186415 METHOD FOR PRODUCTION OF CYTOCHROME P450 WITH N-TERMINAL TRUNCATED P450 REDUCTASE 07-23-2009
25. 20090180985 BRIDGED CARBOCYCLIC OXIME HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS 07-16-2009
26. 20090180984 MACROCYCLIC OXIMYL HEPATITIS C SERINE PROTEASE INHIBITORS 07-16-2009
27. 20090180983 BICYCLIC, C5-SUBSTITUTED PROLINE DERIVATIVES AS INHIBITORS OF THE HEPATITIS C VIRUS NS3 PROTEASE 07-16-2009
28. 20090175822 C5-SUBSTITUTED, PROLINE-DERIVED, MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 07-09-2009
29. 20090162441 PULMONARY DELIVERY IN TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM 06-25-2009
30. 20090156800 PROCESS FOR MAKING MACROCYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS 06-18-2009
31. 20090156427 Bio-Sensing Nanodevice - comprising: a stabilized biologically-derived G-protein coupled receptor--the olfactory receptor--on a support 06-18-2009
32. 20090155210 OXIMYL HCV SERINE PROTEASE INHIBITORS - The present invention discloses compounds of formula I or pharmaceutically acceptable salts esters 06-18-2009
33. 20090149491 CARBOCYCLIC OXIME HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS 06-11-2009
34. 20090148406 Stable Aqueous Systems Comprising Proteins 06-11-2009
35. 20090143487 Enhanced stability of proteins immobilized on nanoparticles 06-04-2009
36. 20090143403 Methods for Administering Aripiprazole - in part to the discovery that a pharmaceutical composition comprising aripiprazole and a carrier administered 06-04-2009
37. 20090142299 MACROCYCLIC TETRAZOLYL HEPATITIS C SERINE PROTEASE INHIBITORS 06-04-2009
38. 20090136538 Stable vaccine formulation - aqueous vaccine composition comprises a protein adsorbed on a solid and one or more stabilising agents 05-28-2009
39. 20090131343 USE OF BRIDGED MACROLIDES OR TYLOSIN DERIVATIVES IN TREATING INFLAMMATORY BOWEL DISEASES 05-21-2009
40. 20090130059 TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 05-21-2009
41. 20090123570 COMPOSITION AND METHOD FOR TREATING SORE THROAT 05-14-2009
42. 20090123454 METHODS FOR TREATING ADHESIVE CAPSULITIS 05-14-2009
43. 20090123425 MACROCYCLIC, PYRIDAZINONE-CONTAINING HEPATITIS C SERINE PROTEASE INHIBITORS 05-14-2009
44. 20090123423 HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS SERINE PROTEASE INHIBITOR 05-14-2009
45. 20090118506 6,11-BRIDGED BIARYL MACROLIDES - The present invention discloses compounds of formula I II or or pharmaceutically acceptable salts 05-07-2009
46. 20090112297 Skin Tanning and Light Therapy Incorporating Light Emitting Diodes 04-30-2009
47. 20090111897 REVERSIBLE BIOGEL FOR MANIPULATION AND SEPARATION OF SINGLE-WALLED CARBON NANOTUBES 04-30-2009
48. 20090111772 FORMULATION OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY 04-30-2009
49. 20090105201 Pulmonary Pharmaceutical Formulations - improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of 04-23-2009
50. 20090098085 TETRAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 04-16-2009
51. 20090093507 CDK INHIBITORS CONTAINING A ZINC BINDING MOIETY 04-09-2009
52. 20090082713 METHOD OF ENHANCING IONTOPHORETIC DELIVERY OF A PEPTIDE 03-26-2009
53. 20090082224 POLYMERS - The application discloses a process for making a polymer having pendant side groups comprising: polymerising an olefinically unsaturated 03-26-2009
54. 20090081061 PERIPHERALLY PIVOTED OSCILLATING VANE MACHINE 03-26-2009
55. 20090076044 VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY 03-19-2009
56. 20090076022 TARTRATE SALTS OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY 03-19-2009
57. 20090076006 HSP90 INHIBITORS CONTAINING A ZINC BINDING MOIETY 03-19-2009
58. 20090075915 6,11-BICYCLOLIDES: BRIDGED BIARYL MACROLIDE DERIVATIVES 03-19-2009
59. 20090069547 STABILIZATION OF MAMMALIAN MEMBRANE PROTEINS BY SHORT SURFACTANT PEPTIDES 03-12-2009
60. 20090068274 HIGHLY EFFICIENT DELIVERY OF A LARGE THERAPEUTIC MASS AEROSOL 03-12-2009
61. 20090060874 BICYCLIC PYRROLIDINE DERIVATIVES - The present invention discloses compounds of formula or pharmaceutically acceptable salts esters 03-05-2009
62. 20090054317 POLYVALENT INHIBITORS OF PATHOGENS - polyvalent host cell receptor-directed pathogen inhibitors and methods for designing and using such polyvalent 02-26-2009
63. 20090053175 SUBSTITUTE PYRROLIDINE DERIVATIVES - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 02-26-2009
64. 20090047248 TRIAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 02-19-2009
65. 20090047247 Pyrrolidine Derivatives - The present invention discloses compounds of formula or pharmaceutically acceptable salts esters 02-19-2009
66. 20090041721 ARYLALKOXYL HEPATITIS C VIRUS PROTEASE INHIBITORS 02-12-2009
67. 20090036350 Method for Stabilisation of a Protein Solution by Addition of Hydroxyl Radical Quenchers and its Sterilisation by Ionising Radiation 02-05-2009
68. 20090035272 Pyridazinonyl Macrocyclic Hepatitis C Serine Protease Inhibitors 02-05-2009
69. 20090035271 TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 02-05-2009
70. 20090035268 TETRAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 02-05-2009
71. 20090035267 ACYCLIC, PYRIDAZINONE-DERIVED HEPATITIS C SERINE PROTEASE INHIBITORS 02-05-2009
72. 20090022823 Methods for Administering Active Agents to CYP3A4 Sensitive Patients 01-22-2009
73. 20090022689 C4-SPIRO-PYRROLIDINE ANTIVIRALS - The present invention discloses compounds of Formula or pharmaceutically acceptable salts esters 01-22-2009
74. 20090010918 METHODS FOR TREATMENT USING COLLAGENASE - Methods for treatment by collagenase injections are provided which are effective in dissolving and lysing a 01-08-2009
75. 20090005387 QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS 01-01-2009
76. 20090004140 4-SUBSTITUTED PYRROLIDINE AS ANTI-INFECTIVES 01-01-2009
77. 20080317865 Quench liquids and washing systems for production of microparticles 12-25-2008
78. 20080317712 ARYLPIPERIDINYL AND ARYLPYRROLIDINYL TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS 12-25-2008
79. 20080300348 Polymer - The application provides a method of producing a comb polymer comprising the steps of: Providing: a plurality of monomers which are linear 12-04-2008
80. 20080292587 OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS 11-27-2008
81. 20080287449 AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS 11-20-2008
82. 20080286233 PIPERIZINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 11-20-2008
83. 20080281075 ASYMMETRIC SYNTHESIS OF PEPTIDES - process comprising substitution of an acceptor molecule comprising a group --XC-- wherein X is O, S or NR 11-13-2008
84. 20080279821 ARYLPIPERIDINYL AND ARYLPYRROLIDINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 11-13-2008
85. 20080274082 OXIMYL HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS PROTEASE INHIBITOR 11-06-2008
86. 20080274080 AZA-PEPTIDE MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS 11-06-2008
87. 20080269228 HYDRAZIDE-CONTAINING HEPATITIS C SERINE PROTEASE INHIBITORS 10-30-2008
88. 20080267918 QUINOXALINYL DIPEPTIDE HEPATITIS C VIRUS INHIBITORS 10-30-2008
89. 20080267917 N-FUNCTIONALIZED AMIDES AS HEPATITIS C SERINE PROTEASE INHIBITORS 10-30-2008
90. 20080267916 CYCLIC P3 TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS 10-30-2008
91. 20080262208 6-11 Bridged Oxime Erythromycin Derivatives 10-23-2008
92. 20080261986 PHARMACEUTICAL FORMULATIONS FOR IONTOPHORETIC DELIVERY OF AN ANTI-FUNGAL DRUG 10-23-2008
93. 20080257713 CATALYTIC REACTORS WITH ACTIVE BOUNDARY LAYER CONTROL 10-23-2008
94. 20080253971 Particles for inhalation having sustained release properties 10-16-2008
95. 20080249339 Charged Polymers for Ethanol Dehydration 10-09-2008
96. 20080248105 POLYMORPHIC FORMS OF 6-11 BICYCLIC KETOLIDE DERIVATIVES 10-09-2008
97. 20080242865 PROCESSES FOR THE PREPARATION OF HYDROXYLAMINES 10-02-2008
98. 20080241253 Formulations for Spray-Drying Large Porous Particles 10-02-2008
99. 20080234629 WATER ELECTROLYSIS TO FACILITATE DRUG DELIVERY BY IONTOPHORESIS 09-25-2008
100. 20080234355 DNA METHYL TRANSFERASE INHIBITORS CONTAINING A ZINC BINDING MOIETY 09-25-2008
101. 20080234332 RAF KINASE INHIBITORS CONTAINING A ZINC BINDING MOIETY 09-25-2008
102. 20080234314 FUSED AMINO PYRIDINE AS HSP90 INHIBITORS 09-25-2008
103. 20080234297 HSP90 Inhibitors Containing a Zinc Binding Moiety 09-25-2008
104. 20080233614 PRODUCTION OF RECOMBINANT COLLAGENASES COLG AND COLH IN ESCHERICHIA COLI 09-25-2008
105. 20080233199 Coacervation Process - Methods of forming compositions for the sustained release of water soluble active agents including biologically active 09-25-2008
106. 20080227804 Polymorphic Forms of Naltrexone - This invention relates to the discovery of novel polymorphic forms of naltrexone including solvates 09-18-2008
107. 20080227690 PARTICLES FOR INHALATION HAVING RAPID RELEASE PROPERTIES 09-18-2008
108. 20080226730 PARTICLES FOR INHALATION HAVING RAPID RELEASE PROPERTIES 09-18-2008
109. 20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents 09-11-2008
110. 20080217013 TUNABLE SURFACTANTS FOR OIL RECOVERY APPLICATIONS 09-11-2008
111. 20080213319 CHEMOREPULSION OF CELLS - compositions and methods of controlling the direction and/or movement of migratory cells 09-04-2008
112. 20080200543 Immunomodulating Agent, Anti-Cancer Agent and Health Food Containing Monoacetyldiacylglycerol Derivatives 08-21-2008